dimethyl (2-oxo-2-(3-(trifluoromethyl)phenyl)ethyl)phosphonate | 51638-14-3

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: dimethyl (2-oxo-2-(3-(trifluoromethyl)phenyl)ethyl)phosphonate
• 英文别名: [3-(Trifluoromethyl)phenacyl]phosphonic acid dimethyl ester；2-dimethoxyphosphoryl-1-[3-(trifluoromethyl)phenyl]ethanone
• CAS: 51638-14-3
• 化学式: C₁₁H₁₂F₃O₄P
• 分子量: 296.183
• InChiKey: JMRVSZYHEIAMLG-UHFFFAOYSA-N

物化性质

• 沸点：
  339.2±42.0 °C(Predicted)
• 密度：
  1.320±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.8
• 重原子数：
  19
• 可旋转键数：
  5
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.36
• 拓扑面积：
  52.6
• 氢给体数：
  0
• 氢受体数：
  7

反应信息

• 作为反应物：
  描述：

  dimethyl (2-oxo-2-(3-(trifluoromethyl)phenyl)ethyl)phosphonate 在 palladium on activated charcoal sodium hydroxide 、 氢气 、 N,N-二异丙基乙胺 、 lithium chloride 作用下， 以 甲醇 、 乙酸乙酯 、 乙腈 为溶剂， 20.0 ℃ 、101.33 kPa 条件下， 反应 1.5h， 生成 7-{(S)-2-Oxo-5-[3-oxo-3-(3-trifluoromethyl-phenyl)-propyl]-pyrrolidin-1-yl}-heptanoic acid
  参考文献：
  名称：

  Lactams as EP4 prostanoid receptor subtype selective agonists. Part 1: 2-Pyrrolidinones-stereochemical and lower side-chain optimization

  摘要：

  A series of 7-[(5R)-substituted 2-oxo-1-pyrrolidinyl]-heptanoic acids were prepared, their isomeric purity determined, and pharmacologically evaluated. Lactams with affinity for the EP4 receptor displayed agonist behavior. The lower side-chain of the lactam template could be substituted to afford ligands (e.g., 17, 24, 30, 31, and 33) of high potency and greater than 1000-fold affinity for EP4 versus the other EP prostanoid receptors. (C) 2004 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2004.01.063
• 作为产物：
  描述：

  3-三氟甲基苯甲酸甲酯 、 甲基膦酸二甲酯 在 正丁基锂 、 溶剂黄146 作用下， 以 四氢呋喃 、 正己烷 、 水 为溶剂， 生成 dimethyl (2-oxo-2-(3-(trifluoromethyl)phenyl)ethyl)phosphonate
  参考文献：
  名称：

  2,5,6,7-tetranor-4,8-inter-m-phenylene PGI.sub.2 derivatives

  摘要：

  本文披露了一种展现出优异体内持续时间和活性的新型前列腺素I.sub.2（PGI.sub.2）衍生物，所述衍生物由以下一般式表示：##STR1##其中R.sub.1、X、R.sub.2和R.sub.3如本文所定义。

  公开号：

  US04775692A1

文献信息

• Solvent-controlled direct radical oxyphosphorylation of styrenes mediated by Manganese(III)
  作者：Guo-Yu Zhang、Cheng-Kun Li、Da-Peng Li、Run-Sheng Zeng、Adedamola Shoberu、Jian-Ping Zou

  DOI：10.1016/j.tet.2016.04.013

  日期：2016.6

  Direct radical oxyphosphorylation of styrenes with diarylphosphine oxides and dialkyl phosphites mediated by Mn(OAc)3 is described. The solvent played a key role in this selective difunctionalization reaction.

  描述了由Mn（OAc）3介导的苯乙烯与二芳基膦氧化物和亚磷酸二烷基酯的直接自由基氧基磷酸化。溶剂在该选择性双官能化反应中起关键作用。
• 8-Aza-11-deoxy prostaglandin analogues
  申请人：——

  公开号：US20030120079A1

  公开（公告）日：2003-06-26

  This invention relates to compounds which are generally EP 4 receptor agonists and which are represented by Formula I: 1 wherein A is a —CH 2 —CH 2 —, or —CH═CH—; B is absent, an aryl, or heteroaryl group; R 1 is alkyl, alkenyl, alkynyl, cycloalkylalkyl, heterocyclylalkyl, aryl, arylalkyl or heteroaryl, when B is aryl or heteroaryl and R 3 , R 4 , R 5 and R 6 are not simultaneously hydrogen, or R 1 is heterocyclylalkyl, aryl, or heteroaryl when B is absent and R 3 , R 4 , R 5 and R 6 are simultaneously hydrogen; and the other substituents are as defined in the specification; or individual isomers, racemic or non-racemic mixtures of isomers, or pharmaceutically acceptable salts or solvates thereof. The invention further relates to pharmaceutical compositions containing such compounds, methods for their use as therapeutic agents, and methods of preparation thereof.

  本发明涉及一般为EP4受体激动剂的化合物，其表示为式I：其中A为—CH2—CH2—，或—CH═CH—；B为不存在、芳基或杂芳基；R1为烷基、烯烃基、炔烃基、环烷基烷基、杂环烷基烷基、芳基、芳基烷基或杂芳基，当B为芳基或杂芳基且R3、R4、R5和R6不同时为氢时，或者R1为杂环烷基烷基、芳基或杂芳基，当B为不存在且R3、R4、R5和R6同时为氢时；其他取代基如规范中所定义；或其单体异构体、消旋或非消旋异构体混合物，或其药学上可接受的盐或溶剂。该发明还涉及含有此类化合物的药物组合物、用作治疗剂的方法以及其制备方法。
• 2,5,6,7-tetranor-4,8-inter-m-phenylene PGI2 derivatives
  申请人：TORAY INDUSTRIES, INC.

  公开号：EP0232776A2

  公开（公告）日：1987-08-19

  Disclosed herein are novel prostaglandin I2 (PGI2) derivatives exhibiting excellent in vivo duration and acitivities, said derivatives being represented by the general formula: wherein R1, X, R2 and R3 are as defined herein.

  本文公开了新型前列腺素 I2 (PGI2) 衍生物，其在体内的持续时间和活性极佳，所述衍生物由通式表示： 其中 R1、X、R2 和 R3 如本文所定义。
• Direct Radical Acetoxyphosphorylation of Styrenes Mediated by Manganese(III)
  作者：Shao-Fang Zhou、Da-Peng Li、Kui Liu、Jian-Ping Zou、Olayinka Taiwo Asekun

  DOI：10.1021/jo5023298

  日期：2015.1.16

  Direct radical acetoxyphosphorylation of styrenes mediated by Mn(OAc)(3) with diphenylphosphine oxide and dialkyl phosphites was described, and a new type of difunctionalization of alkenes was achieved.
• PROSTAGLANDIN ANALOGUES-AS EP4 RECEPTOR AGONISTS
  申请人：F. HOFFMANN-LA ROCHE AG

  公开号：EP1409455A1

  公开（公告）日：2004-04-21